LOGIN  |  REGISTER
Amneal Pharmaceuticals
Viking Therapeutics

Psychemedics Launches New Ketamine Hair Testing Service

August 29, 2024 | Last Trade: US$2.67 0.00 0.00

DALLAS, Aug. 29, 2024 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ: PMD), a global leader in hair testing, is proud to announce the launch of its new ketamine hair testing solution. This innovative testing method marks a significant advancement in the detection and prevention for a drug-free workplace and community.

Ketamine, a powerful dissociative anesthetic and emerging drug of abuse, poses a growing concern for employers, educators, and law enforcement agencies. With the introduction of this new testing service, Psychemedics aims to equip organizations with the tools needed to identify and address ketamine use effectively.

Key Features and Benefits of Ketamine Hair Testing

  1. Long Detection Window: Unlike traditional drug testing methods, hair analysis can detect ketamine use for up to 90 days, providing a comprehensive overview of an individual’s drug use history.
  2. Non-Invasive and Convenient: The hair collection process is simple and noninvasive and can be performed without the need for specialized facilities, making it ideal for various testing environments.
  3. High Sensitivity and Specificity: Utilizing advanced technology, Psychemedics’ ketamine hair test ensures highly accurate results, minimizing the risk of false positives and negatives.
  4. Comprehensive Drug Panel: This new service can be integrated into existing multi-drug panels offered by Psychemedics, allowing for a broad-spectrum approach to drug testing.
  5. Support for Various Industries: The ketamine hair test is designed to meet the needs of diverse sectors, including workplace safety programs, educational institutions, rehabilitation centers, law enforcement agencies, and many others.

“We are thrilled to introduce ketamine hair testing as part of our commitment to delivering the most reliable and comprehensive drug testing solutions,” said Brian Hullinger, CEO and President of Psychemedics. “This new offering underscores our dedication to innovation and our mission to support organizations in maintaining safe and drug-free environments.”

Psychemedics’ ketamine hair testing service is now available to clients and partners. For more information about this new service or to schedule a consultation, please contact Psychemedics at This email address is being protected from spambots. You need JavaScript enabled to view it. or visit our website at https://www.psychemedics.com.

About Psychemedics 

Psychemedics Corporation is a leading global provider of innovative hair testing for drugs of abuse. With a commitment to accuracy and reliability, the company offers cutting-edge drug testing solutions. Psychemedics Corporation is dedicated to providing valuable insights and maintaining the highest standards in substance abuse testing.

Investor Relations:
Phone: 978-206-8220
Email: This email address is being protected from spambots. You need JavaScript enabled to view it. 

Assertio

Stock Quote

Featured Stock

Amneal Pharmaceuticals

Amneal Pharmaceuticals is a fully-integrated essential medicines company. We make healthy possible through the development, manufacturing, and distribution of generic and specialty pharmaceuticals. The Company has a diverse portfolio of over 250 products in its Generics segment and is expanding across...

CLICK TO LEARN MORE

Featured Stock

Immix Biopharma

Immix Biopharma is a clinical-stage biopharmaceutical company pioneering a novel class of CAR-T cell therapies and Tissue-Specific Therapeutics targeting oncology and immuno-dysregulated diseases with >75 patients treated to-date. Our lead cell therapy asset is NXC-201...

CLICK TO LEARN MORE

End of content

No more pages to load

Next page